Fig. 4From: Preoperative risk stratification for early recurrence of HBV-related hepatocellular carcinoma after deceased donor liver transplantation: a five-eight model development and validationIn the training cohort, the 2-year recurrence rates according to AFP model (a), according to the 5–8 model for patients within the AFP model (b) and in patients outside AFP model (c). In the validation cohort, the 2-year recurrence rates (d) according to the 5–8 modelBack to article page